Top Markets
Coin of the day
PCL, Inc. PCL, Inc.

PCL, Inc.

241820
Classifica tra le azioni #31791
PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic... PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.
Prezzo delle azioni
$0.21291741
Ultima sincronizzazione: 2025-04-18
Capitalizzazione di mercato
$12.07M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
KR
Scambia PCL, Inc. (241820)

Categoria

Rapporto P/B per PCL, Inc. (241820)
Rapporto P/B al August 2026 TTM: 0.31
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di PCL, Inc., il rapporto P/B attuale (TTM) è 0.31. Alla fine del 2023, era pari a 4.33.
Storico del rapporto P/B per PCL, Inc. da 2015 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
2026 (TTM) 0.31 -92.92%
2024 4.37 0.92%
2023 4.33 -22.84%
2022 5.61 -79.76%
2021 27.74 158.91%
2020 10.71 -23.63%
2019 14.03 43.20%
2018 9.80 -11.87%
2017 11.12 -9.46%
2016 12.28 -33.14%
2015 18.36 0.00%
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
3.7944 1,126.37%
US
5.423 1,652.75%
US
2.0146 551.13%
IE
3.072 892.89%
US
4.9725 1,507.14%
US